CH

Christiane Heinz Hamacher

Director Director DIN 07822113
DIN 07822113 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2017
Shareholding value •••• Premium profile

About Christiane Heinz Hamacher

Data last updated:

Christiane Heinz Hamacher was a Director at Roche Products (India) Private Limited (2017–2018) and Managing Director at Biocon Biologics Limited (2019–2021). The companies operate in Pharma.

DIN 07822113
Primary Designation Director
Industry Pharma
First Appointment 25 May 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 May 20171994₹1,296 Cr (FY 2024)Active
Biocon Biologics Limited U24119KA2016PLC093936
Managing Director11 Oct 20192016₹10,144 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Roche Products (India) Private Limited
Biocon Biologics Limited
Premium access

Shareholding and investment profile for Christiane Heinz Hamacher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Christiane Heinz Hamacher

Christiane Heinz Hamacher was first appointed on 25 May 2017 as Director at Roche Products (India) Private Limited. The most recent appointment on record is 11 Oct 2019 at Biocon Biologics Limited.

Christiane Heinz Hamacher held 2 earlier board appointments: Roche Products (India) Private Limited (Director, 25 May 2017 to 26 Jul 2018); Biocon Biologics Limited (Managing Director, 11 Oct 2019 to 21 Jan 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available